Recursion Pharmaceuticals | Investor Day Presentation Deck

Slide schematic 5/5

callout 1/1 diagram 1/1 paragraph 2/2 title 1/1

Components 5

primary process paragraph paragraph headline

Tools 1

Problem Statement Canvas slide · 70%

Outcome Measures: Primary (PK, % Change from Baseline in Polyp Burden), Secondary (Safety, PK, PD, Histological grade), Exploratory (PD, Time to first occurrence of FAP-related event)

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

clinical-trial-design 90%

The slide maps out the phases, enrollment, and treatment arms of a clinical trial.

Find anything

The slide outlines a two-part clinical trial design (Part 1 and Part 2) with specific enrollment criteria and outcome measures.